Mabylon

Switzerland
Schlieren, Zurich, Switzerland

Company profile

Mabylon company profile

Mabylon is a biotechnology company that leverages a technology platform to discover and engineer antibody therapeutics. It focuses on therapies for allergies, inflammation, and neurology. The company's goal is to rapidly create antibody libraries from which therapeutically relevant products are selected.

Business identity

Contact email
[email protected]
Phone number
41 44 731 94 09
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$18.6M
Last funding
Undisclosed / $18.6M / 2025-08-12
Last equity funding
Undisclosed / $18.6M
Investors
3
Articles
31

Founders and investors

Investors

InnosuisseTarget ALS FoundationThe ALS Association